Shopping Cart

Remove All
Your shopping cart is currently empty

Tyrosine Kinase/Adaptors

Discoidin Domain Receptor (DDR)

PYK2

Pyk2 is a Novel Tau Tyrosine Kinase that is Regulated by the Tyrosine Kinase Fyn,the protein tyrosine kinase Pyk2 is encoded by PTK2B,Pyk2 Non-receptor protein-tyrosine kinase that regulates reorganization of the actin cytoskeleton, cell polarization, cell migration, adhesion, spreading and bone remodeling. Plays a role in the regulation of the humoral immune response,.

Filter HomeSignaling PathwaysTyrosine Kinase/AdaptorsPYK2

PF-562271

T2465717907-75-0

PF-562271 is an effective ATP-competitive, reversible inhibitor of FAK(IC50=1.5 nM) and Pyk2 kinase(IC50=13 nM).

In Stock

Size

QTY

Cited

PF-562271 hydrochloride

T21768939791-41-0

PF-562271 hydrochloride (PF-562271 HCl) is a potent, ATP-competitive, reversible inhibitor of FAK with IC50 of 1.5 nM in cell-free assays, ~10-fold less potent for Pyk2 than FAK and >100-fold selectivity against other protein kinases, except for some CDKs.

In Stock

Size

QTY

PF-562271 besylate

T6177939791-38-5

PF-562271 besylate (PF-00562271 Besylate) is a potent, ATP-competitive, reversible inhibitor of FAK with IC50 of 1.5 nM, ~10-fold less potent for Pyk2 than FAK and >100-fold selectivity against other protein kinases, except for some CDKs.

In Stock

Size

QTY

PF-431396

T2314717906-29-1

PF-431396 is a dual PYK2 FAK inhibitor (IC50: 11 2 nM).

In Stock

Size

QTY

Cited

AZ7550

T135641421373-99-0

AZ7550, an active metabolite of AZD9291, inhibits the activity of IGF1R (IC50: 1.6 μM).

$133

In Stock

Size

QTY

NVP-TAE 226

T1918761437-28-9

NVP-TAE 226 (TAE226) is a potent FAK inhibitor (IC50: 5.5 nM), exhibiting even greater efficacy against Pyk2 (IC50: 3.5 nM), and is 10- to 100-fold less effective against IGF-1R, InsR, c-Met, and ALK.

In Stock

Size

QTY

Cited

PF-4618433

T223971166393-85-6

PF-4618433 is a selective PYK2 inhibitor with osteogenic activity.

$330

In Stock

Size

QTY

Conteltinib

T149971384860-29-0In house

Conteltinib (CT-707) is an enzyme inhibitor with antitumor activity targeting FAK, ALK, and Pyk2.Conteltinib exhibits significant inhibition of FAK, overcomes hypoxia-mediated sorafenib resistance in hepatocellular carcinoma through inhibition of YAP signaling, and can be used in advanced ALK-positive non-small-cell lung cancer and lymphoma.

In Stock

Size

QTY

FAK-IN-14

T778112766666-22-0

FAK-IN-14 is a highly effective focal adhesion kinase (FAK) inhibitor that induces apoptosis and cell cycle arrest. FAK-IN-14 has weak inhibitory effects on Akt, c-kit, MEK1 2 and mTOR, but has significant inhibitory effects on FAK, FGFR1 and Pyk2.

In Stock

Size

QTY

Go to page 1

Page of 1